Two Drugs Approved for Cardiomyopathy Caused by Amyloidosis

Two different versions of tafamadis get the FDA ’s nod to treat a rare heart disease. 

Source: ConsultantLive - May 6, 2019 Category: Internal Medicine Authors: Valerie DeBenedette Tags: Cardiology Cardiovascular Diseases Heart Health Latest e-News New Products The Latest Source Type: news